NO20020998L - Mesoprogestiner (progesteronreseptormodulater) som en komponent i svangerskapsforebyggelse for kvinner - Google Patents

Mesoprogestiner (progesteronreseptormodulater) som en komponent i svangerskapsforebyggelse for kvinner

Info

Publication number
NO20020998L
NO20020998L NO20020998A NO20020998A NO20020998L NO 20020998 L NO20020998 L NO 20020998L NO 20020998 A NO20020998 A NO 20020998A NO 20020998 A NO20020998 A NO 20020998A NO 20020998 L NO20020998 L NO 20020998L
Authority
NO
Norway
Prior art keywords
mesoprogestins
women
component
progesterone receptor
pregnancy prevention
Prior art date
Application number
NO20020998A
Other languages
English (en)
Other versions
NO20020998D0 (no
Inventor
Kristof Chwalisz
Walter Elger
Gerd Schubert
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of NO20020998D0 publication Critical patent/NO20020998D0/no
Publication of NO20020998L publication Critical patent/NO20020998L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
NO20020998A 1999-08-31 2002-02-28 Mesoprogestiner (progesteronreseptormodulater) som en komponent i svangerskapsforebyggelse for kvinner NO20020998L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38613399A 1999-08-31 1999-08-31
PCT/IB2000/002053 WO2001026603A2 (en) 1999-08-31 2000-08-31 Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives

Publications (2)

Publication Number Publication Date
NO20020998D0 NO20020998D0 (no) 2002-02-28
NO20020998L true NO20020998L (no) 2002-03-14

Family

ID=23524305

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020998A NO20020998L (no) 1999-08-31 2002-02-28 Mesoprogestiner (progesteronreseptormodulater) som en komponent i svangerskapsforebyggelse for kvinner

Country Status (28)

Country Link
EP (1) EP1605949A2 (no)
JP (1) JP2003511399A (no)
KR (1) KR20020038745A (no)
CN (1) CN1384748A (no)
AR (1) AR025455A1 (no)
AU (1) AU781835B2 (no)
BG (1) BG106441A (no)
BR (1) BR0013711A (no)
CA (1) CA2383650A1 (no)
CO (1) CO5190694A1 (no)
CZ (1) CZ2002707A3 (no)
EA (1) EA006805B1 (no)
EE (1) EE200200103A (no)
HR (1) HRP20020265A2 (no)
HU (1) HUP0202515A3 (no)
IL (1) IL148415A0 (no)
LT (1) LT5001B (no)
LV (1) LV12940B (no)
MX (1) MXPA02002186A (no)
NO (1) NO20020998L (no)
NZ (1) NZ517470A (no)
PE (1) PE20010579A1 (no)
PL (1) PL353994A1 (no)
SI (1) SI20853A (no)
SK (1) SK2982002A3 (no)
UA (1) UA77150C2 (no)
WO (1) WO2001026603A2 (no)
YU (1) YU13902A (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
ES2273061T3 (es) * 2002-08-02 2007-05-01 Schering Aktiengesellschaft Agentes moduladores de receptores de progesterona con actividad antigonadotropa elevada para el control de fertilidad femenina y para la terapia por reemplazo hormonal.
US7772219B2 (en) * 2003-05-02 2010-08-10 Teva Women's Health, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
US20050215535A1 (en) * 2004-03-24 2005-09-29 Kristof Chwalisz Sequential SPRM/progestin treatment
EP1773344A1 (en) * 2004-07-07 2007-04-18 Wyeth a Corporation of the State of Delaware Cyclic progestin regimens and kits
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
CN102395373A (zh) * 2009-04-14 2012-03-28 Hra医药实验室 按需避孕方法
CN110548034A (zh) * 2019-07-12 2019-12-10 广州莎蔓生物科技有限公司 一种怀孕阻断药物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054271A (en) 1932-05-17 1936-09-15 Schering Kahlbaum Ag Production of crystallized hormone esters
DE699310C (de) 1936-11-20 1940-11-27 Chemische Ind Ges Verfahren zur Herstellung von in 3-Stellung veresterten Verbindungen vom Typus des Oestradiols
US2225419A (en) 1937-03-01 1940-12-17 Schering Corp Process for the conversion of 17-cisalcohols of the cyclopentanopolyhydrophenanthrene series into the corresponding 17-trans-alcohols
US2611773A (en) 1951-08-21 1952-09-23 Upjohn Co Estradiol 17-cyclopenetanepropionate
US2990414A (en) 1957-03-26 1961-06-27 Syntex Sa 17-undecenoate of estradiol
DE3337450A1 (de) 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
ES2169030T3 (es) * 1987-09-24 2002-07-01 Jencap Res Ltd Envases de anticonceptivos que contienen estrogeno y progestina.
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
US5516769A (en) 1993-02-19 1996-05-14 The Medical College Of Hampton Roads Method of inhibiting fertilization
DE4332283A1 (de) 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4429397C2 (de) 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE4429398C2 (de) 1994-08-09 1997-09-11 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption
IL115738A (en) * 1994-10-24 2002-05-23 Schering Ag Competitive progesterone antibodies to regulate female fertility as required
US6040340A (en) * 1996-05-07 2000-03-21 Schering Aktiengesellschaft Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors
TR199802705T2 (xx) * 1996-06-25 1999-03-22 Akzo Nobel N.V. Progestojen-anti-progestojen k�r�
WO1998005679A2 (en) * 1996-08-05 1998-02-12 Duke University Mixed agonists of the progesterone receptor and assays therefor
DE19809845A1 (de) * 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
EP1175422A2 (en) * 1999-05-04 2002-01-30 Ligand Pharmaceuticals Incorporated Tetracyclic progesterone receptor modulator compounds and methods

Also Published As

Publication number Publication date
AU3215001A (en) 2001-04-23
NZ517470A (en) 2004-03-26
EA200200284A1 (ru) 2002-10-31
SI20853A (sl) 2002-10-31
AU781835B2 (en) 2005-06-16
CO5190694A1 (es) 2002-08-29
LT2002035A (lt) 2002-10-25
CZ2002707A3 (cs) 2002-11-13
PL353994A1 (en) 2003-12-15
HUP0202515A2 (hu) 2002-12-28
SK2982002A3 (en) 2002-07-02
HUP0202515A3 (en) 2004-06-28
IL148415A0 (en) 2002-09-12
UA77150C2 (en) 2006-11-15
WO2001026603A2 (en) 2001-04-19
PE20010579A1 (es) 2001-06-04
YU13902A (sh) 2006-01-16
EP1605949A2 (en) 2005-12-21
KR20020038745A (ko) 2002-05-23
EE200200103A (et) 2003-04-15
NO20020998D0 (no) 2002-02-28
BG106441A (bg) 2002-09-30
HRP20020265A2 (en) 2004-02-29
AR025455A1 (es) 2002-11-27
CN1384748A (zh) 2002-12-11
JP2003511399A (ja) 2003-03-25
MXPA02002186A (es) 2002-09-02
LT5001B (lt) 2003-03-25
BR0013711A (pt) 2002-05-07
CA2383650A1 (en) 2001-04-19
EA006805B1 (ru) 2006-04-28
WO2001026603A3 (en) 2002-01-17
LV12940B (en) 2003-06-20

Similar Documents

Publication Publication Date Title
GB2337618B (en) Interface for synchronous semiconductor memories
SG129308A1 (en) Handler system for cutting a semiconductor packagedevice
EP1164595A4 (en) SEMICONDUCTOR DEVICE
SG97903A1 (en) Semiconductor device
TW576544U (en) Semiconductor device
GB0000106D0 (en) Semiconductor device
DK1068202T3 (da) 1-(-heteroarylpropyl- eller -prop-2-enyl)-4benzylpipderidiner som NMDA-receptor-antagonister
GB2355486B (en) Fastening device for interconnecting two parts
EP1304134A4 (en) AUXILIARY DEVICE FOR APPLYING AN ADHESIVE
PL366225A1 (en) Device for connecting to each other three flat elements
NO20020998D0 (no) Mesoprogestiner (progesteronreseptormodulater) som en komponent i svangerskapsforebyggelse for kvinner
DE60037846D1 (de) Synchronhalbleiterspeicheranordnung
GB2347014B (en) Semiconductor device
GB2356489B (en) Semiconductor device
EP1229591A4 (en) SEMICONDUCTOR DEVICE
EP1220071A4 (en) SEMICONDUCTOR DEVICE
IL147616A0 (en) Extending synchronous busses by arbitrary lengths using native bus protocol
SG90760A1 (en) Synchronous semiconductor storage device
AU3511900A (en) Bovine pregnancy testing
NO20015378D0 (no) Cyclocarbamatderivater som progesteron reseptor modulatorer
TW551607U (en) Advanced semiconductor device testing system
GB9927215D0 (en) Hormone receptor expression
EP1211733A4 (en) SEMICONDUCTOR DEVICE
FI991219A (fi) Laite hakkeen ylisuuren jakeen pienentämiseksi
GB2348556B (en) Semiconductor device

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application